BlackRock Inc. - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$808,395
-8.1%
78,485
+47.0%
0.00%
Q2 2023$879,768
+103.5%
53,384
+13.1%
0.00%
Q1 2023$432,343
+57.6%
47,199
+23.2%
0.00%
Q4 2022$274,357
+60.4%
38,318
+12.5%
0.00%
Q3 2022$171,000
+144.3%
34,069
+18.4%
0.00%
Q2 2022$70,000
-72.1%
28,770
-21.6%
0.00%
Q1 2022$251,000
+3.7%
36,706
+22.7%
0.00%
Q4 2021$242,000
-17.4%
29,924
+0.0%
0.00%
Q3 2021$293,000
+77.6%
29,915
+21.7%
0.00%
Q2 2021$165,000
-96.4%
24,578
-95.2%
0.00%
Q1 2021$4,604,000
+18.1%
509,284
-12.7%
0.00%
Q4 2020$3,898,000
+83.7%
583,668
+20.7%
0.00%
Q3 2018$2,122,000
-29.1%
483,369
-1.0%
0.00%
Q2 2018$2,992,000
-19.9%
488,138
-4.7%
0.00%
Q1 2018$3,735,000
-19.0%
512,451
-8.9%
0.00%
Q4 2017$4,611,000
-24.7%
562,339
-3.6%
0.00%
Q3 2017$6,124,000
+5.6%
583,254
+10.9%
0.00%
Q2 2017$5,799,000
+10.2%
525,738
-3.3%
0.00%
Q1 2017$5,263,000543,7240.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,409,289$24,815,67612.25%
Knoll Capital Management, LLC 600,000$6,180,0006.42%
Vivo Capital, LLC 4,096,428$42,193,2084.62%
GENDELL JEFFREY L 5,615,350$57,838,1053.29%
Tri Locum Partners LP 983,602$10,131,1013.24%
Samsara BioCapital, LLC 967,527$9,965,5283.05%
MPM BioImpact LLC 664,224$6,841,5071.83%
COWEN AND COMPANY, LLC 2,338,302$24,084,5101.68%
RTW INVESTMENTS, LP 7,136,415$73,505,0751.55%
TANG CAPITAL MANAGEMENT LLC 1,000,000$10,300,0001.45%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders